MX2016004660A - Composiciones de peptido novedosas. - Google Patents
Composiciones de peptido novedosas.Info
- Publication number
- MX2016004660A MX2016004660A MX2016004660A MX2016004660A MX2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A MX 2016004660 A MX2016004660 A MX 2016004660A
- Authority
- MX
- Mexico
- Prior art keywords
- novel peptide
- peptide compositions
- compositions
- novel
- things
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361890056P | 2013-10-11 | 2013-10-11 | |
| US201461940095P | 2014-02-14 | 2014-02-14 | |
| PCT/US2014/058646 WO2015054006A2 (en) | 2013-10-11 | 2014-10-01 | Novel peptide compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016004660A true MX2016004660A (es) | 2016-11-14 |
Family
ID=52813728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016004660A MX2016004660A (es) | 2013-10-11 | 2014-10-01 | Composiciones de peptido novedosas. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9133241B2 (enExample) |
| EP (1) | EP3054967A4 (enExample) |
| JP (1) | JP2017501967A (enExample) |
| KR (1) | KR20160065969A (enExample) |
| CN (1) | CN105828831A (enExample) |
| AU (1) | AU2014332346B2 (enExample) |
| BR (1) | BR112016007816A2 (enExample) |
| CA (1) | CA2926641A1 (enExample) |
| CL (1) | CL2016000836A1 (enExample) |
| IL (1) | IL244956B (enExample) |
| MX (1) | MX2016004660A (enExample) |
| RU (1) | RU2016112931A (enExample) |
| SG (1) | SG11201602661PA (enExample) |
| WO (1) | WO2015054006A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017150327A1 (ja) * | 2016-03-03 | 2017-09-08 | 不二製油グループ本社株式会社 | 神経栄養因子の脳内分泌促進するための食品添加用組成物 |
| JP6983247B2 (ja) * | 2017-02-16 | 2021-12-17 | ケアジェン カンパニー, リミテッドCaregen Co., Ltd. | サリチル酸とペプチドとの結合体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244946A (en) | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
| US4305872A (en) | 1979-10-19 | 1981-12-15 | Kenneth Wingrove | Polypeptide derivatives |
| US4316891A (en) | 1980-06-14 | 1982-02-23 | The Salk Institute For Biological Studies | Extended N-terminal somatostatin |
| US20020168761A1 (en) | 2000-01-24 | 2002-11-14 | Gour Barbara J. | Peptidomimetic modulators of cell adhesion |
| WO1998002452A2 (en) | 1996-07-12 | 1998-01-22 | Mcgill University | Compounds and methods for modulating cell adhesion |
| US7563862B2 (en) | 2001-08-24 | 2009-07-21 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods for their use in treatment of brain damage |
| WO2003018754A2 (en) | 2001-08-24 | 2003-03-06 | Neuronz Limited | Neural regeneration peptide and methods for their use in treatment of brain damage |
| AU2003293807A1 (en) * | 2002-12-24 | 2004-07-22 | Algonomics N.V. | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
| WO2005042561A2 (en) | 2003-10-31 | 2005-05-12 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods of use |
| WO2007011595A2 (en) * | 2005-07-15 | 2007-01-25 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and antioxidants protect neurons from degeneration |
| AU2011274474B2 (en) * | 2010-07-09 | 2015-06-18 | Dana-Farber Cancer Institute, Inc. | Stabilized insulinotropic peptides and methods of use |
| US20130210726A1 (en) * | 2012-02-10 | 2013-08-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of peripheral vascular disease |
-
2014
- 2014-10-01 MX MX2016004660A patent/MX2016004660A/es unknown
- 2014-10-01 AU AU2014332346A patent/AU2014332346B2/en not_active Ceased
- 2014-10-01 EP EP14852391.3A patent/EP3054967A4/en not_active Withdrawn
- 2014-10-01 CA CA2926641A patent/CA2926641A1/en not_active Abandoned
- 2014-10-01 JP JP2016521985A patent/JP2017501967A/ja active Pending
- 2014-10-01 KR KR1020167011913A patent/KR20160065969A/ko not_active Withdrawn
- 2014-10-01 WO PCT/US2014/058646 patent/WO2015054006A2/en not_active Ceased
- 2014-10-01 CN CN201480066852.9A patent/CN105828831A/zh active Pending
- 2014-10-01 BR BR112016007816A patent/BR112016007816A2/pt not_active Application Discontinuation
- 2014-10-01 SG SG11201602661PA patent/SG11201602661PA/en unknown
- 2014-10-01 RU RU2016112931A patent/RU2016112931A/ru not_active Application Discontinuation
- 2014-10-03 US US14/506,497 patent/US9133241B2/en not_active Expired - Fee Related
-
2015
- 2015-08-04 US US14/817,735 patent/US20170275333A1/en not_active Abandoned
-
2016
- 2016-04-06 IL IL24495616A patent/IL244956B/en not_active IP Right Cessation
- 2016-04-11 CL CL2016000836A patent/CL2016000836A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2926641A1 (en) | 2015-04-16 |
| BR112016007816A2 (pt) | 2017-12-05 |
| WO2015054006A2 (en) | 2015-04-16 |
| RU2016112931A3 (enExample) | 2018-06-20 |
| AU2014332346B2 (en) | 2019-01-24 |
| IL244956B (en) | 2019-10-31 |
| RU2016112931A (ru) | 2017-11-16 |
| US20170275333A1 (en) | 2017-09-28 |
| WO2015054006A3 (en) | 2015-06-04 |
| EP3054967A2 (en) | 2016-08-17 |
| JP2017501967A (ja) | 2017-01-19 |
| US9133241B2 (en) | 2015-09-15 |
| SG11201602661PA (en) | 2016-05-30 |
| AU2014332346A1 (en) | 2016-05-05 |
| IL244956A0 (en) | 2016-05-31 |
| CL2016000836A1 (es) | 2016-09-16 |
| EP3054967A4 (en) | 2017-04-19 |
| US20150105335A1 (en) | 2015-04-16 |
| KR20160065969A (ko) | 2016-06-09 |
| CN105828831A (zh) | 2016-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014501924A1 (en) | Xten conjugate compositions and methods of making same | |
| PH12017500866A1 (en) | Targeted xten conjugate compositions and methods of making same | |
| MX2016006053A (es) | Compuestos selectivos de peptido yy (pyy) y usos de los mismos. | |
| MY187047A (en) | Selective pyy compounds and uses thereof | |
| IN2013MU03583A (enExample) | ||
| MY161773A (en) | Amylin analogues and pharmaceutical compositions thereof | |
| BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
| MX362432B (es) | Variantes de oxm pegilada. | |
| IN2014DN00101A (enExample) | ||
| EP3626253A3 (en) | Stable formulations of linaclotide | |
| MX2018014023A (es) | Compuestos de citocina inhibidora de macrofagos 1 (mic-1) y uso de estos. | |
| EA201591752A1 (ru) | Дипептидные и трипептидные эпоксикетонные ингибиторы протеазы | |
| PH12019550241A1 (en) | Mic-1 compounds and uses thereof | |
| CY1119036T1 (el) | Νεοι αγωνιστες του υποδοχεα τυπου 2 της αγγειοτενσινης (ατ2) και χρησεις τους | |
| MX370923B (es) | Formulacion de relacion fija de insulina glargina/lixisenatida. | |
| TN2019000087A1 (en) | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors | |
| MX2020012989A (es) | Agente terapeutico para la fibrosis. | |
| TN2013000386A1 (en) | Suspension type topical formulations comprising cyclic depsipeptide | |
| NZ732301A (en) | Peptide compound, preparation method therefor, and application thereof | |
| EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
| WO2015024022A3 (en) | Designed peptides for tight junction barrier modulation | |
| MX362058B (es) | Péptido pntx(19) sintético, composición farmacéutica y uso. | |
| CL2021001479A1 (es) | Péptido; uso de composiciones; composición farmacéutica; uso de un anticuerpo para terapia; uso de un anticuerpo para elisa, inmunohistoquímica y/o formación de imágenes; receptor de linfocito t; y uso de un linfocito t citotóxico activado (divisional de la solicitud n° 201701391) | |
| BR112015022730A2 (pt) | formulações de rfviii, método para conjugação covalente de rfviii com um polímero biocompatível e uso de rfviii no preparo de formulação de rfviii para tratamento de hemofilia a | |
| WO2015054006A3 (en) | Novel peptide compositions |